Warby Parker (WRBY) Competitors

$28.84 +0.35 (+1.21%)

As of 03:52 PM Eastern

WRBY vs. GKOS, BLCO, STVN, IRTC, and LIVN

Should you buy Warby Parker stock or one of its competitors? MarketBeat compares Warby Parker with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Warby Parker include Glaukos (GKOS), Bausch + Lomb (BLCO), Stevanato Group (STVN), iRhythm Technologies (IRTC), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry.

How does Warby Parker compare to Glaukos?

Glaukos (NYSE:GKOS) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations, dividends and media sentiment.

Warby Parker has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glaukos	$507.44M	16.38	-$187.69M	-$3.28	N/A
Warby Parker	$871.91M	3.54	$1.64M	$0.02	1,441.80

99.0% of Glaukos shares are owned by institutional investors. Comparatively, 93.2% of Warby Parker shares are owned by institutional investors. 5.8% of Glaukos shares are owned by company insiders. Comparatively, 16.8% of Warby Parker shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Warby Parker has a net margin of 0.15% compared to Glaukos' net margin of -34.34%. Warby Parker's return on equity of 2.30% beat Glaukos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Glaukos	-34.34%	-6.92%	-5.25%
Warby Parker	0.15%	2.30%	1.18%

Glaukos has a beta of 0.94, suggesting that its share price is 6% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.95, suggesting that its share price is 95% more volatile than the broader market.

Glaukos currently has a consensus price target of $144.42, indicating a potential upside of 2.07%. Warby Parker has a consensus price target of $29.00, indicating a potential upside of 0.57%. Given Glaukos' stronger consensus rating and higher possible upside, research analysts plainly believe Glaukos is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glaukos	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.86
Warby Parker	0 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.63

In the previous week, Warby Parker had 13 more articles in the media than Glaukos. MarketBeat recorded 19 mentions for Warby Parker and 6 mentions for Glaukos. Warby Parker's average media sentiment score of 0.54 beat Glaukos' score of 0.14 indicating that Warby Parker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Glaukos	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Warby Parker	8 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Warby Parker beats Glaukos on 11 of the 17 factors compared between the two stocks.

How does Warby Parker compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, media sentiment and dividends.

Warby Parker has a net margin of 0.15% compared to Bausch + Lomb's net margin of -4.21%. Bausch + Lomb's return on equity of 3.60% beat Warby Parker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-4.21%	3.60%	1.69%
Warby Parker	0.15%	2.30%	1.18%

11.1% of Bausch + Lomb shares are owned by institutional investors. Comparatively, 93.2% of Warby Parker shares are owned by institutional investors. 1.5% of Bausch + Lomb shares are owned by insiders. Comparatively, 16.8% of Warby Parker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Warby Parker has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$5.10B	1.14	-$360M	-$0.62	N/A
Warby Parker	$871.91M	3.54	$1.64M	$0.02	1,441.80

In the previous week, Warby Parker had 14 more articles in the media than Bausch + Lomb. MarketBeat recorded 19 mentions for Warby Parker and 5 mentions for Bausch + Lomb. Warby Parker's average media sentiment score of 0.54 beat Bausch + Lomb's score of 0.16 indicating that Warby Parker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch + Lomb	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Warby Parker	8 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Bausch + Lomb currently has a consensus price target of $18.08, indicating a potential upside of 11.29%. Warby Parker has a consensus price target of $29.00, indicating a potential upside of 0.57%. Given Bausch + Lomb's higher probable upside, equities analysts plainly believe Bausch + Lomb is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1 Sell rating(s)	9 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.21
Warby Parker	0 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.63

Bausch + Lomb has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.95, suggesting that its stock price is 95% more volatile than the broader market.

Summary

Warby Parker beats Bausch + Lomb on 12 of the 16 factors compared between the two stocks.

How does Warby Parker compare to Stevanato Group?

Warby Parker (NYSE:WRBY) and Stevanato Group (NYSE:STVN) are both mid-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.

Warby Parker presently has a consensus price target of $29.00, suggesting a potential upside of 0.57%. Given Warby Parker's stronger consensus rating and higher possible upside, research analysts plainly believe Warby Parker is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Warby Parker	0 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.63
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Stevanato Group has a net margin of 11.76% compared to Warby Parker's net margin of 0.15%. Stevanato Group's return on equity of 10.27% beat Warby Parker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Warby Parker	0.15%	2.30%	1.18%
Stevanato Group	11.76%	10.27%	6.08%

Warby Parker has a beta of 1.95, suggesting that its share price is 95% more volatile than the broader market. Comparatively, Stevanato Group has a beta of 0.75, suggesting that its share price is 25% less volatile than the broader market.

93.2% of Warby Parker shares are held by institutional investors. 16.8% of Warby Parker shares are held by company insiders. Comparatively, 0.7% of Stevanato Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Stevanato Group has higher revenue and earnings than Warby Parker. Stevanato Group is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Warby Parker	$871.91M	3.54	$1.64M	$0.02	1,441.80
Stevanato Group	€1.34B	3.98	€158.21M	€0.59	29.91

In the previous week, Warby Parker had 11 more articles in the media than Stevanato Group. MarketBeat recorded 19 mentions for Warby Parker and 8 mentions for Stevanato Group. Warby Parker's average media sentiment score of 0.54 beat Stevanato Group's score of 0.15 indicating that Warby Parker is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Warby Parker	8 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Stevanato Group	0 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Warby Parker beats Stevanato Group on 9 of the 16 factors compared between the two stocks.

How does Warby Parker compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

iRhythm Technologies presently has a consensus price target of $193.38, suggesting a potential upside of 68.45%. Warby Parker has a consensus price target of $29.00, suggesting a potential upside of 0.57%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe iRhythm Technologies is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.93
Warby Parker	0 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.63

93.2% of Warby Parker shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by company insiders. Comparatively, 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Warby Parker has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$787.85M	4.79	-$44.55M	-$0.86	N/A
Warby Parker	$871.91M	3.54	$1.64M	$0.02	1,441.80

Warby Parker has a net margin of 0.15% compared to iRhythm Technologies' net margin of -3.53%. Warby Parker's return on equity of 2.30% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Warby Parker	0.15%	2.30%	1.18%

In the previous week, Warby Parker had 14 more articles in the media than iRhythm Technologies. MarketBeat recorded 19 mentions for Warby Parker and 5 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.47 beat Warby Parker's score of 0.54 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Warby Parker	8 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies has a beta of 1.33, meaning that its share price is 33% more volatile than the broader market. Comparatively, Warby Parker has a beta of 1.95, meaning that its share price is 95% more volatile than the broader market.

Summary

Warby Parker beats iRhythm Technologies on 11 of the 17 factors compared between the two stocks.

How does Warby Parker compare to LivaNova?

Warby Parker (NYSE:WRBY) and LivaNova (NASDAQ:LIVN) are both mid-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 16.8% of Warby Parker shares are owned by company insiders. Comparatively, 0.4% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Warby Parker has higher earnings, but lower revenue than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Warby Parker	$871.91M	3.54	$1.64M	$0.02	1,441.80
LivaNova	$1.43B	2.76	-$242.47M	$1.95	36.90

Warby Parker currently has a consensus price target of $29.00, suggesting a potential upside of 0.57%. LivaNova has a consensus price target of $77.22, suggesting a potential upside of 7.32%. Given LivaNova's stronger consensus rating and higher possible upside, analysts clearly believe LivaNova is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Warby Parker	0 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.63
LivaNova	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70

LivaNova has a net margin of 7.48% compared to Warby Parker's net margin of 0.15%. LivaNova's return on equity of 16.48% beat Warby Parker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Warby Parker	0.15%	2.30%	1.18%
LivaNova	7.48%	16.48%	7.59%

In the previous week, Warby Parker had 11 more articles in the media than LivaNova. MarketBeat recorded 19 mentions for Warby Parker and 8 mentions for LivaNova. LivaNova's average media sentiment score of 0.57 beat Warby Parker's score of 0.54 indicating that LivaNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Warby Parker	8 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
LivaNova	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Warby Parker has a beta of 1.95, suggesting that its stock price is 95% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market.

Summary

LivaNova beats Warby Parker on 9 of the 16 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WRBY vs. The Competition

Export

Metric	Warby Parker	CONS PD Industry	Staples Sector	NYSE Exchange
Market Cap	$3.09B	$30.18B	$16.12B	$23.00B
Dividend Yield	N/A	3.38%	3.49%	4.07%
P/E Ratio	1,445.22	77.99	23.16	28.40
Price / Sales	3.54	1.53	47.48	24.14
Price / Cash	42.83	30.87	16.36	25.11
Price / Book	8.22	11.45	5.27	4.76
Net Income	$1.64M	$1.33B	$671.44M	$1.06B
7 Day Performance	5.74%	-2.30%	-1.35%	-0.67%
1 Month Performance	24.67%	-2.75%	-1.80%	1.83%
1 Year Performance	65.44%	-17.17%	-11.73%	25.08%

Warby Parker Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WRBY Warby Parker	2.5974 of 5 stars	$28.84 +1.2%	$29.00 +0.6%	+54.0%	$3.09B	$871.91M	1,445.22	4,036	Earnings Report Analyst Upgrade Options Volume
GKOS Glaukos	2.5284 of 5 stars	$135.17 +1.2%	$144.42 +6.8%	+48.8%	$7.84B	$507.44M	N/A	1,094	Insider Trade
BLCO Bausch + Lomb	4.2825 of 5 stars	$16.10 -0.5%	$18.08 +12.3%	+36.8%	$5.77B	$5.21B	N/A	13,000	News Coverage
STVN Stevanato Group	2.9974 of 5 stars	€18.29 +0.1%	N/A	-28.0%	€5.54B	€1.34B	31.00	6,010	Earnings Report Gap Up
IRTC iRhythm Technologies	4.3974 of 5 stars	$116.84 -3.2%	$193.38 +65.5%	-18.0%	$3.97B	$747.14M	N/A	2,400

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:WRBY) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Warby Parker (WRBY) Competitors

WRBY vs. GKOS, BLCO, STVN, IRTC, and LIVN

How does Warby Parker compare to Glaukos?

Summary

How does Warby Parker compare to Bausch + Lomb?

Summary

How does Warby Parker compare to Stevanato Group?

Summary

How does Warby Parker compare to iRhythm Technologies?

Summary

How does Warby Parker compare to LivaNova?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WRBY vs. The Competition

Warby Parker Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Warby Parker (WRBY) Competitors

WRBY vs. GKOS, BLCO, STVN, IRTC, and LIVN

How does Warby Parker compare to Glaukos?

Which has higher earnings & valuation, GKOS or WRBY?

Do institutionals & insiders have more ownership in GKOS or WRBY?

Is GKOS or WRBY more profitable?

Which has more volatility & risk, GKOS or WRBY?

Do analysts recommend GKOS or WRBY?

Does the media prefer GKOS or WRBY?

Summary

How does Warby Parker compare to Bausch + Lomb?

Is BLCO or WRBY more profitable?

Do insiders and institutionals have more ownership in BLCO or WRBY?

Which has better earnings and valuation, BLCO or WRBY?

Does the media prefer BLCO or WRBY?

Do analysts recommend BLCO or WRBY?

Which has more risk & volatility, BLCO or WRBY?

Summary

How does Warby Parker compare to Stevanato Group?

Do analysts rate WRBY or STVN?

Is WRBY or STVN more profitable?

Which has more volatility & risk, WRBY or STVN?

Do institutionals and insiders have more ownership in WRBY or STVN?

Which has stronger valuation and earnings, WRBY or STVN?

Does the media refer more to WRBY or STVN?

Summary

How does Warby Parker compare to iRhythm Technologies?

Do analysts recommend IRTC or WRBY?

Do institutionals & insiders hold more shares of IRTC or WRBY?

Which has stronger valuation and earnings, IRTC or WRBY?

Is IRTC or WRBY more profitable?

Does the media refer more to IRTC or WRBY?

Which has more risk and volatility, IRTC or WRBY?

Summary

How does Warby Parker compare to LivaNova?

Do institutionals and insiders hold more shares of WRBY or LIVN?

Which has higher earnings and valuation, WRBY or LIVN?

Do analysts rate WRBY or LIVN?

Is WRBY or LIVN more profitable?

Does the media favor WRBY or LIVN?

Which has more risk and volatility, WRBY or LIVN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WRBY vs. The Competition

Warby Parker Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools